These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 27875783

  • 1. PRAME overexpression predicted good outcome in pediatric B-cell acute lymphoblastic leukemia patients receiving chemotherapy.
    Zhang YH, Lu AD, Yang L, Li LD, Chen WM, Long LY, Zhang LP, Qin YZ.
    Leuk Res; 2017 Jan; 52():43-49. PubMed ID: 27875783
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [Abstract] [Full Text] [Related]

  • 3. High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.
    Cario G, Rhein P, Mitlöhner R, Zimmermann M, Bandapalli OR, Romey R, Moericke A, Ludwig WD, Ratei R, Muckenthaler MU, Kulozik AE, Schrappe M, Stanulla M, Karawajew L.
    Haematologica; 2014 Jan; 99(1):103-10. PubMed ID: 23911702
    [Abstract] [Full Text] [Related]

  • 4. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
    Liu X, Zou Y, Wang H, Chen X, Ruan M, Chen Y, Yang W, Guo Y, Liu T, Zhang L, Wang S, Zhang J, Liu F, Cai X, Qi B, Chang L, Zhu X.
    Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
    [Abstract] [Full Text] [Related]

  • 5. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance.
    Dworzak MN, Fritsch G, Panzer-Grümayer ER, Mann G, Gadner H.
    Leuk Lymphoma; 2000 Jul; 38(3-4):295-308. PubMed ID: 10830736
    [Abstract] [Full Text] [Related]

  • 6. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
    Lepretre S, Touzart A, Vermeulin T, Picquenot JM, Tanguy-Schmidt A, Salles G, Lamy T, Béné MC, Raffoux E, Huguet F, Chevallier P, Bologna S, Bouabdallah R, Benichou J, Brière J, Moreau A, Tallon-Simon V, Seris S, Graux C, Asnafi V, Ifrah N, Macintyre E, Dombret H.
    J Clin Oncol; 2016 Feb 20; 34(6):572-80. PubMed ID: 26644537
    [Abstract] [Full Text] [Related]

  • 7. Prognosis of pediatric BCP-ALL with IKZF1 deletions and impact of intensive chemotherapy: Results of SCCLG-2016 study.
    Lin S, Liao N, Li X, Yang L, He YY, Tang YL, Wan WQ, Jia W, Zhang YJ, Kong Q, Long X, Lan X, Ling YY, Lin D, Zhang XL, Wen C, Li CK, Xu HG.
    Eur J Haematol; 2024 Sep 20; 113(3):357-370. PubMed ID: 38847134
    [Abstract] [Full Text] [Related]

  • 8. The relevance of preferentially expressed antigen of melanoma (PRAME) as a marker of disease activity and prognosis in acute promyelocytic leukemia.
    Santamaría C, Chillón MC, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, Ramos F, Bernal T, Queizán JA, Peñarrubia MJ, Giraldo P, San Miguel JF, Gonzalez M.
    Haematologica; 2008 Dec 20; 93(12):1797-805. PubMed ID: 18815192
    [Abstract] [Full Text] [Related]

  • 9. Quantitative assessment of PRAME expression in diagnosis of childhood acute leukemia.
    Spanaki A, Perdikogianni C, Linardakis E, Kalmanti M.
    Leuk Res; 2007 May 20; 31(5):639-42. PubMed ID: 16860864
    [Abstract] [Full Text] [Related]

  • 10. Minimal residual disease-based treatment is adequate for relapse-prone childhood acute lymphoblastic leukemia with an intrachromosomal amplification of chromosome 21: the experience of the ALL-BFM 2000 trial.
    Attarbaschi A, Panzer-Grümayer R, Mann G, Möricke A, König M, Mecklenbräuker A, Teigler-Schlegel A, Bradtke J, Harbott J, Göhring G, Stanulla M, Schrappe M, Zimmermann M, Haas OA, Austrian and German ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Klin Padiatr; 2014 Nov 20; 226(6-7):338-43. PubMed ID: 25431866
    [Abstract] [Full Text] [Related]

  • 11. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
    Gao YJ, Pan C, Tang JY, Lu FJ, Chen J, Xue HL, Zhai XW, Li J, Ye QD, Zhou M, Wang HS, Miao H, Qian XW, Xu Z, Meng JH.
    Pediatr Blood Cancer; 2014 Apr 20; 61(4):659-63. PubMed ID: 24243691
    [Abstract] [Full Text] [Related]

  • 12. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
    Ratei R, Schabath R, Karawajew L, Zimmermann M, Möricke A, Schrappe M, Ludwig WD.
    Klin Padiatr; 2013 May 20; 225 Suppl 1():S34-9. PubMed ID: 23700065
    [Abstract] [Full Text] [Related]

  • 13. Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.
    Troeger A, Siepermann M, Escherich G, Meisel R, Willers R, Gudowius S, Moritz T, Laws HJ, Hanenberg H, Goebel U, Janka-Schaub GE, Mahotka C, Dilloo D.
    Haematologica; 2007 Aug 20; 92(8):1043-50. PubMed ID: 17640858
    [Abstract] [Full Text] [Related]

  • 14. The prognostic significance of Wilms' tumor gene 1 (WT1) expression at diagnosis in adults with Ph-negative B cell precursor acute lymphoblastic leukemia.
    Qin YZ, Jiang Q, Xu LP, Jiang H, Wang Y, Zhao XS, Li ZR, Lai YY, Liu YR, Zhang XH, Liu KY, Huang XJ.
    Ann Hematol; 2019 Nov 20; 98(11):2551-2559. PubMed ID: 31493003
    [Abstract] [Full Text] [Related]

  • 15. PRAME gene expression in childhood acute lymphoblastic leukemia.
    Steinbach D, Viehmann S, Zintl F, Gruhn B.
    Cancer Genet Cytogenet; 2002 Oct 01; 138(1):89-91. PubMed ID: 12419593
    [Abstract] [Full Text] [Related]

  • 16. Prognostic value of karyotypic analysis in children and adults with high-risk acute lymphoblastic leukemia included in the PETHEMA ALL-93 trial.
    Ribera JM, Ortega JJ, Oriol A, Granada I, Hernández-Rivas JM, Parody R, Bethencourt C, Rivas C, Bastida P, del Potro E, González-Valentín ME, Moreno MJ, Besalduch J, Fernández-Calvo J, Tormo M, Arias J, Molinés A, Sanz MA, Maldonado J, Millá F, Feliu E, San Miguel JF, PETHEMA Group, Spanish Society of Hematology.
    Haematologica; 2002 Feb 01; 87(2):154-66. PubMed ID: 11836166
    [Abstract] [Full Text] [Related]

  • 17. PRAME gene expression in childhood acute lymphoblastic leukemia: impact on prognosis.
    Abdelmalak CA, Yahya RS, Elghannam DM, El-Khadragy AE, Abd El Messih HM.
    Clin Lab; 2014 Feb 01; 60(1):55-61. PubMed ID: 24600975
    [Abstract] [Full Text] [Related]

  • 18. Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma.
    Lee WJ, Moon HR, Won CH, Chang SE, Choi JH, Moon KC, Lee MW.
    J Am Acad Dermatol; 2014 Feb 01; 70(2):318-25. PubMed ID: 24314877
    [Abstract] [Full Text] [Related]

  • 19. [Analysis of clinical features and prognostic significance of childhood T-lineage acute lymphoblastic leukemia].
    Zhang YL, Zhao WL, Nie SS, Guo DD, Ji ZH, Chai YH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec 01; 19(6):1496-500. PubMed ID: 22169311
    [Abstract] [Full Text] [Related]

  • 20. CD200/BTLA deletions in pediatric precursor B-cell acute lymphoblastic leukemia treated according to the EORTC-CLG 58951 protocol.
    Ghazavi F, Clappier E, Lammens T, Suciu S, Caye A, Zegrari S, Bakkus M, Grardel N, Benoit Y, Bertrand Y, Minckes O, Costa V, Ferster A, Mazingue F, Plat G, Plouvier E, Poirée M, Uyttebroeck A, van der Werff-Ten Bosch J, Yakouben K, Helsmoortel H, Meul M, Van Roy N, Philippé J, Speleman F, Cavé H, Van Vlierberghe P, De Moerloose B.
    Haematologica; 2015 Oct 01; 100(10):1311-9. PubMed ID: 26137961
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.